Membership
Tour
Register
Log in
Medicinal preparations containing organic active ingredients
Follow
Industry
CPC
A61K31/00
This industry / category may be too specific. Please go to a parent level for more data
Parent Industries
A
HUMAN NECESSITIES
A61
Medical science
A61K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Current Industry
A61K31/00
Medicinal preparations containing organic active ingredients
Sub Industries
A61K31/01
Hydrocarbons
A61K31/015
carbocyclic
A61K31/02
Halogenated hydrocarbons
A61K31/025
carbocyclic
A61K31/03
aromatic
A61K31/035
having aliphatic unsaturation
A61K31/04
Nitro compounds
A61K31/045
Hydroxy compounds
A61K31/047
having two or more hydroxy groups
A61K31/05
Phenols
A61K31/055
the aromatic ring being substituted by halogen
A61K31/06
the aromatic ring being substituted by nitro groups
A61K31/065
Diphenyl-substituted acyclic alcohols
A61K31/07
Retinol compounds
A61K31/075
Ethers or acetals
A61K31/08
acyclic
A61K31/085
having an ether linkage to aromatic ring nuclear carbon
A61K31/09
having two or more such linkages
A61K31/095
Sulfur, selenium, or tellurium compounds
A61K31/10
Sulfides Sulfoxides Sulfones
A61K31/105
Persulfides
A61K31/11
Aldehydes
A61K31/115
Formaldehyde
A61K31/12
Ketones
A61K31/121
acyclic
A61K31/122
having the oxygen directly attached to a ring
A61K31/125
Camphor Nuclear substituted derivatives thereof
A61K31/13
Amines
A61K31/131
acylic
A61K31/132
having two or more amino groups
A61K31/133
having hydroxy groups
A61K31/135
having aromatic rings
A61K31/136
having the amino group directly attached to the aromatic ring
A61K31/137
Arylalkylamines
A61K31/138
Aryloxyalkylamines
A61K31/14
Quaternary ammonium compounds
A61K31/145
having sulfur
A61K31/15
Oximes (>C=N-O-) Hydrazines (>N-N<) Hydrazones (>N-N=) Imines (C-N=C)
A61K31/155
Amidines ()
A61K31/16
Amides
A61K31/164
of a carboxlic acid with an aminoalcohol
A61K31/165
having aromatic rings
A61K31/166
having the carbon of a carboxamide group directly attached to the aromatic ring
A61K31/167
having the nitrogen of a carboxamide group directly attached to the aromatic ring
A61K31/17
having the group >N-C(O)-N< or >N-C(S)-N<
A61K31/175
having the group , >N-C(O)-N=N- or
A61K31/18
Sulfonamides
A61K31/185
Acids Anhydrides, halides or salts thereof
A61K31/19
Carboxylic acids
A61K31/191
having two or more hydroxy groups
A61K31/192
having aromatic groups
A61K31/194
having two or more carboxyl groups
A61K31/195
having an amino group
A61K31/196
the amino group being directly attached to a ring
A61K31/197
the amino and the carboxyl group being attached to the same acyclic carbon chain
A61K31/198
Alpha-aminoacids
A61K31/20
having a carboxyl group bound to a chain of seven or more carbon atoms
A61K31/201
having one or two double bonds
A61K31/202
having three or more double bonds
A61K31/203
Retinoic acids Salts thereof
A61K31/205
Amine addition salts of organic acids Inner quaternary ammonium salts
A61K31/21
Esters
A61K31/215
of carboxylic acids
A61K31/216
of acids having aromatic rings
A61K31/22
of acyclic acids
A61K31/221
with compounds having an amino group
A61K31/222
with compounds having aromatic groups
A61K31/223
of alpha-aminoacids
A61K31/225
Polycarboxylic acids
A61K31/23
of acids having a carboxyl group bound to a chain of seven or more carbon atoms
A61K31/231
having one or two double bonds
A61K31/232
having three or more double bonds
A61K31/235
having an aromatic ring attached to a carboxyl group
A61K31/24
having an amino or nitro group
A61K31/245
Amino benzoic acid types
A61K31/25
with polyoxyalkylated alcohols
A61K31/255
of sulfoxy acids or sulfur analogues thereof
A61K31/26
Cyanate or isoyanate esters Thiocyanate or isothiocyanate esters
A61K31/265
of carbonic, thiocarbonic, or thiocarboxylic acids
A61K31/27
of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
A61K31/275
Nitriles Isonitriles
A61K31/277
having a ring
A61K31/28
Compounds containing heavy metals
A61K31/282
Platinum compounds
A61K31/285
Arsenic compounds
A61K31/29
Antimony or bismuth compounds
A61K31/295
Iron group metal compounds
A61K31/30
Copper compounds
A61K31/305
Mercury compounds
A61K31/31
containing nitrogen
A61K31/315
Zinc compounds
A61K31/32
Tin compounds
A61K31/325
Carbamic acids Thiocarbamic acids Anhydrides or salts thereof
A61K31/327
Peroxy compounds
A61K31/33
Heterocyclic compounds
A61K31/335
having oxygen as the only ring hetero atom
A61K31/336
having three-membered rings
A61K31/337
having four-membered rings
A61K31/34
having five-membered rings with one oxygen as the only ring hetero atom
A61K31/341
not condensed with another ring
A61K31/343
condensed with a carbocyclic ring
A61K31/345
Nitrofurans
A61K31/35
having six-membered rings with one oxygen as the only ring hetero atom
A61K31/351
not condensed with another ring
A61K31/352
condensed with carbocyclic rings
A61K31/353
3,4-Dihydrobenzopyrans
A61K31/355
Tocopherols
A61K31/357
having two or more oxygen atoms in the same ring
A61K31/36
Compounds containing methylenedioxyphenyl groups
A61K31/365
Lactones
A61K31/366
having six-membered rings
A61K31/37
Coumarins
A61K31/375
Ascorbic acid
A61K31/38
having sulfur as a ring hetero atom
A61K31/381
having five-membered rings
A61K31/382
having six-membered rings
A61K31/385
having two or more sulfur atoms in the same ring
A61K31/39
having oxygen in the same ring
A61K31/395
having nitrogen as a ring hetero atom
A61K31/396
having thre-membered rings
A61K31/397
having four-membered rings
A61K31/40
having five-membered rings with one nitrogen as the only ring hetero atom
A61K31/401
Proline Derivatives thereof
A61K31/4015
having oxo groups directly attached to the heterocyclic ring
A61K31/402
1-aryl substituted
A61K31/4025
not condensed and containing further heterocyclic rings
A61K31/403
condensed with carbocyclic rings
A61K31/4035
Isoindoles
A61K31/404
Indoles
A61K31/4045
Indole-alkylamines Amides thereof
A61K31/405
Indole-alkanecarboxylic acids Derivatives thereof
A61K31/407
condensed with other heterocyclic ring systems
A61K31/409
having four such rings
A61K31/41
having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen
A61K31/415
1,2-Diazoles
A61K31/4152
having oxo groups directly attached to the heterocyclic ring
A61K31/4155
non condensed and containing further heterocyclic rings
A61K31/416
condensed with carbocyclic ring systems
A61K31/4162
condensed with heterocyclic ring systems
A61K31/4164
1,3-Diazoles
A61K31/4166
having oxo groups directly attached to the heterocyclic ring
A61K31/4168
having a nitrogen attached in position 2
A61K31/417
Imidazole-alkylamines
A61K31/4172
Imidazole-alkanecarboxylic acids
A61K31/4174
Arylalkylimidazoles
A61K31/4178
not condensed 1,3-diazoles and containing further heterocyclic rings
A61K31/4184
condensed with carbocyclic rings
A61K31/4188
condensed with other heterocyclic ring systems
A61K31/4192
1,2,3-Triazoles
A61K31/4196
1,2,4-Triazoles
A61K31/42
Oxazoles
A61K31/421
1,3-Oxazoles
A61K31/422
not condensed and containing further heterocyclic rings
A61K31/423
condensed with carbocyclic rings
A61K31/424
condensed with heterocyclic ring systems
A61K31/4245
Oxadiazoles
A61K31/425
Thiazoles
A61K31/426
1,3-Thiazoles
A61K31/427
not condensed and containing further heterocyclic rings
A61K31/428
condensed with carbocyclic rings
A61K31/429
condensed with heterocyclic ring systems
A61K31/43
Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula
A61K31/431
containing further heterocyclic rings
A61K31/433
Thidiazoles
A61K31/435
having six-membered rings with one nitrogen as the only ring hetero atom
A61K31/4353
ortho- or peri-condensed with heterocyclic ring systems
A61K31/4355
the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
A61K31/436
the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e..g. rapamycin
A61K31/4365
the heterocyclic ring system having sulfur as a ring hetero atom
A61K31/437
the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom
A61K31/4375
the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom
A61K31/438
the ring being spiro-condensed with carbocyclic ring systems
A61K31/439
the ring forming part of a bridged ring system
A61K31/44
Non condensed pyridines Hydrogenated derivatives thereof
A61K31/4402
only substituted in position 2
A61K31/4406
only substituted in position 3
A61K31/4409
only substituted in position 4
A61K31/4412
having oxo groups directly attached to the heterocyclic ring
A61K31/4415
Pyridoxine
A61K31/4418
having a carbocyclic group directly attached to the heterocyclic ring
A61K31/4422
1,4-Dihydropyridines
A61K31/4425
Pyridinium derivatives
A61K31/4427
containing further heterocyclic ring systems
A61K31/443
containing a five-membered ring with oxygen as a ring hetero atom
A61K31/4433
containing a six-membered ring with oxygen as a ring hetero atom
A61K31/4436
containing a heterocyclic ring having sulfur as a ring hetero atom
A61K31/4439
containing a five-membered ring with nitrogen as a ring hetero atom
A61K31/444
containing a six-membered ring with nitrogen as a ring heteroatom
A61K31/445
Non condensed piperidines
A61K31/4453
only substituted in position 1
A61K31/4458
only substituted in position 2
A61K31/4462
only substituted in position 3
A61K31/4465
only substituted in position 4
A61K31/4468
having a nitrogen directly attached in position 4
A61K31/45
having oxo groups directly attached to the heterocyclic ring
A61K31/451
having a carbocyclic group directly attached to the heterocyclic ring
A61K31/4515
having a butyrophenone group in position 1
A61K31/452
Piperidinium derivatives
A61K31/4523
containing further heterocyclic ring systems
A61K31/4525
containing a five-membered ring with oxygen as a ring hetero atom
A61K31/453
containing a six-membered ring with oxygen as a ring hetero atom
A61K31/4535
containing a heterocyclic ring having sulfur as a ring hetero atom
A61K31/454
containing a five-membered ring with nitrogen as a ring hetero atom
A61K31/4545
containing a six-membered ring with nitrogen as a ring hetero atom
A61K31/455
Nicotinic acids
A61K31/46
8-Azabicyclo [3.2.1] octane Derivatives thereof
A61K31/465
Nicotine Derivatives thereof
A61K31/47
Quinolines Isoquinolines
A61K31/4704
2-Quinolinones
A61K31/4706
4-Aminoquinolines 8-Aminoquinolines
A61K31/4709
Non-condensed quinolines and containing further heterocyclic rings
A61K31/472
Non-condensed isoquinolines
A61K31/4725
containing further heterocyclic rings
A61K31/473
ortho- or peri-condensed with carbocyclic ring systems
A61K31/4738
ortho- or peri-condensed with heterocyclic ring systems
A61K31/4741
condensed with ring systems having oxygen as a ring hetero atom
A61K31/4743
condensed with ring systems having sulfur as a ring hetero atom
A61K31/4745
condensed with ring systems having nitrogen as a ring hetero atom
A61K31/4747
Spiro-condensed
A61K31/4748
forming part of bridged ring systems
A61K31/475
having an indole ring
A61K31/48
Ergoline derivatives
A61K31/485
Morphinan derivatives
A61K31/49
Cinchonan derivatives
A61K31/495
having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms
A61K31/496
Non-condensed piperazines containing further heterocyclic rings
A61K31/4965
Non-condensed pyrazines
A61K31/497
containing further heterocyclic rings
A61K31/498
Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems
A61K31/4985
Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
A61K31/499
Spiro-condensed pyrazines or piperazines
A61K31/4995
Pyrazines or piperazines forming part of bridged ring systems
A61K31/50
Pyridazines Hydrogenated pyridazines
A61K31/501
not condensed and containing further heterocyclic rings
A61K31/502
ortho- or peri-condensed with carbocyclic ring systems
A61K31/5025
ortho- or peri-condensed with heterocyclic ring systems
A61K31/503
spiro-condensed
A61K31/504
forming part of bridged ring systems
A61K31/505
Pyrimidines Hydrogenated pyrimidines
A61K31/506
not condensed and containing further heterocyclic rings
A61K31/51
Thiamines
A61K31/513
having oxo groups directly attached to the heterocyclic ring
A61K31/515
Barbituric acids Derivatives thereof
A61K31/517
ortho- or peri-condensed with carbocyclic ring systems
A61K31/519
ortho- or peri-condensed with heterocyclic rings
A61K31/52
Purines
A61K31/522
having oxo groups directly attached to the heterocyclic ring
A61K31/525
Isoalloxazines
A61K31/527
spiro-condensed
A61K31/529
forming part of bridged ring systems
A61K31/53
having six-membered rings with three nitrogens as the only ring hetero atoms
A61K31/535
having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms
A61K31/5355
non-condensed oxazines and containing further heterocyclic rings
A61K31/536
ortho- or peri-condensed with carbocyclic ring systems
A61K31/5365
ortho- or peri-condensed with heterocyclic ring systems
A61K31/537
spiro-condensed or forming part of bridged ring systems
A61K31/5375
1,4-Oxazines
A61K31/5377
not condensed and containing further heterocyclic rings
A61K31/538
ortho- or peri-condensed with carbocyclic ring systems
A61K31/5383
ortho- or peri-condensed with heterocyclic ring systems
A61K31/5386
Spiro-condensed or forming part of bridged ring systems
A61K31/539
having two or more oxygen atoms in the same ring
A61K31/5395
having two or more nitrogen atoms in the same ring
A61K31/54
having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms
A61K31/541
non-condensed thiazines containing further heterocyclic rings
A61K31/5415
ortho- or peri-condensed with carbocyclic ring systems
A61K31/542
ortho- or peri-condensed with heterocyclic ring systems
A61K31/545
Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:
A61K31/546
containing further heterocyclic rings
A61K31/547
spiro-condensed or forming part of bridged ring systems
A61K31/548
having two or more sulfur atoms in the same ring
A61K31/549
having two or more nitrogen atoms in the same ring
A61K31/55
having seven-membered rings
A61K31/551
having two nitrogen atoms
A61K31/5513
1,4-Benzodiazepines
A61K31/5517
condensed with five-membered rings having nitrogen as a ring hetero atom
A61K31/553
having at least one nitrogen and one oxygen as ring hetero atoms
A61K31/554
having at least one nitrogen and one sulfur as ring hetero atoms
A61K31/555
containing heavy metals
A61K31/557
Eicosanoids
A61K31/5575
having a cyclopentane
A61K31/5578
having a pentalene ring system
A61K31/558
having heterocyclic rings containing oxygen as the only ring hetero atom
A61K31/5585
having five-membered rings containing oxygen as the only ring hetero atom
A61K31/559
having heterocyclic rings containing hetero atoms other than oxygen
A61K31/56
Compounds containing cyclopenta[a]hydrophenanthrene ring systems Derivatives
A61K31/565
not substituted in position 17 beta by a carbon atom
A61K31/566
having an oxo group in position 17
A61K31/567
substituted in position 17 alpha
A61K31/568
substituted in positions 10 and 13 by a chain having at least one carbon atom
A61K31/5685
having an oxo group in position 17
A61K31/569
substituted in position 17 alpha
A61K31/57
substituted in position 17 beta by a chain of two carbon atoms
A61K31/573
substituted in position 21
A61K31/575
substituted in position 17 beta by a chain of three or more carbon atoms
A61K31/58
containing heterocyclic rings
A61K31/585
containing lactone rings
A61K31/59
Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
A61K31/592
9,10-Secoergostane derivatives, e.g. ergocalciferol
A61K31/593
9,10-Secocholestane derivatives, e.g. cholecalciferol
A61K31/60
Salicylic acid Derivatives thereof
A61K31/603
having further aromatic rings
A61K31/606
having amino groups
A61K31/609
Amides
A61K31/612
having the hydroxy group in position 2 esterified
A61K31/616
by carboxylic acids
A61K31/618
having the carboxyl group in position 1 esterified
A61K31/621
having the hydroxy group in position 2 esterified
A61K31/625
having heterocyclic substituents
A61K31/63
Compounds containing para-N-benzenesulfonyl-N-groups
A61K31/635
having a heterocyclic ring
A61K31/64
Sulfonylureas
A61K31/65
Tetracyclines
A61K31/655
Azo (-N=N-), diazo (=N2), azoxy (>N-O-N< or N(=O)-N<), azido (-N3) or diazoamino (-N=N-N<) compounds
A61K31/66
Phosphorus compounds
A61K31/661
Phosphorus acids or esters thereof not having P-C bonds
A61K31/6615
Compounds having two or more esterified phosphorus acid groups
A61K31/662
Phosphorus acids or esters thereof having P-C bonds
A61K31/663
Compounds having two or more phosphorus acid groups or esters thereof
A61K31/664
Amides of phosphorus acids
A61K31/665
having oxygen as a ring hetero atom
A61K31/67
having sulfur as a ring hetero atom
A61K31/675
having nitrogen as a ring hetero atom
A61K31/683
Diesters of a phosphorus acid with two hydroxy compounds
A61K31/685
one of the hydroxy compounds having nitrogen atoms
A61K31/688
both hydroxy compounds having nitrogen atoms
A61K31/69
Boron compounds
A61K31/695
Silicon compounds
A61K31/70
Carbohydrates Sugars Derivatives thereof
A61K31/7004
Monosaccharide having only carbon, hydrogen and oxygen atoms
A61K31/7008
Compounds having an amino group directly attached to a carbon atom of the saccharide radical
A61K31/7012
Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical
A61K31/7016
Disaccharides
A61K31/702
Oligosaccharides
A61K31/7024
Esters of saccharides
A61K31/7028
Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
A61K31/7032
attached to a polyol, i.e. compound having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage
A61K31/7034
attached to a carbocyclic compound
A61K31/7036
having at least one amino group directly attached to the carbocyclic ring
A61K31/704
attached to a condensed carbocyclic ring system
A61K31/7042
Compounds having saccharide radicals and heterocyclic rings
A61K31/7048
having oxygen as a ring hetero atom
A61K31/7052
having nitrogen as a ring hetero atom
A61K31/7056
containing five-membered rings with nitrogen as a ring hetero atom
A61K31/706
containing six-membered rings with nitrogen as a ring hetero atom
A61K31/7064
containing condensed or non-condensed pyrimidines
A61K31/7068
having oxo groups directly attached to the pyrimidine ring
A61K31/7072
having two oxo groups directly attached to the pyrimidine ring
A61K31/7076
containing purines
A61K31/708
having oxo groups directly attached to the purine ring system
A61K31/7084
Compounds having two nucleosides or nucleotides
A61K31/7088
Compounds having three or more nucleosides or nucleotides
A61K31/7105
Natural ribonucleic acids
A61K31/711
Natural deoxyribonucleic acids
A61K31/7115
Nucleic acids or oligonucleotides having modified bases
A61K31/712
Nucleic acids or oligonucleotides having modified sugars
A61K31/7125
Nucleic acids or oligonucleotides having modified internucleoside linkage
A61K31/713
Double-stranded nucleic acids or oligonucleotides
A61K31/7135
Compounds containing heavy metals
A61K31/714
Cobalamins, e.g. cyanocobalamin
A61K31/715
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages Derivatives thereof
A61K31/716
Glucans
A61K31/717
Celluloses
A61K31/718
Starch or degraded starch
A61K31/719
Pullulans
A61K31/721
Dextrans
A61K31/722
Chitin, chitosan
A61K31/723
Xanthans
A61K31/724
Cyclodextrins
A61K31/726
Glycosaminoglycans
A61K31/727
Heparin Heparan
A61K31/728
Hyaluronic acid
A61K31/729
Agar Agarose Agaropectin
A61K31/731
Carrageenans
A61K31/732
Pectin
A61K31/733
Fructosans
A61K31/734
Alginic acid
A61K31/736
Glucomannans or galactomannans
A61K31/737
Sulfated polysaccharides
A61K31/738
Cross-linked polysaccharides
A61K31/739
Lipopolysaccharides
A61K31/74
Synthetic polymeric materials
A61K31/745
Polymers of hydrocarbons
A61K31/75
of ethene
A61K31/755
Polymers containing halogen
A61K31/76
of vinyl chloride
A61K31/765
Polymers containing oxygen
A61K31/77
of oxiranes
A61K31/775
Phenolic resins
A61K31/78
of acrylic acid or derivatives thereof
A61K31/785
Polymers containing nitrogen
A61K31/787
containing heterocyclic rings having nitrogen as a ring hetero atom
A61K31/79
Polymers of vinyl pyrrolidone
A61K31/795
Polymers containing sulfur
A61K31/80
Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
Industries
Overview
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
Therapeutic, preventive, or improvement agent for inflammatory dise...
Patent number
12,285,434
Issue date
Apr 29, 2025
The University of Tokyo
Takahisa Murata
A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information
Patent Grant
Substituted pyridines as DNMT1 inhibitors
Patent number
12,285,436
Issue date
Apr 29, 2025
GlaxoSmithKline Intellectual Property Development Limited
Andrew B. Benowitz
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Uses of glycosaminoglycan conjugates
Patent number
12,285,441
Issue date
Apr 29, 2025
Holy Stone Healthcare Co., Ltd.
Hua-Yang Lin
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Fasting-mimicking diet promotes cancer-free survival in acute lymph...
Patent number
12,285,453
Issue date
Apr 29, 2025
University of Southern California
Valter D. Longo
A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information
Patent Grant
Pharmaceutical composition in solid extruded form
Patent number
12,285,486
Issue date
Apr 29, 2025
SE Tylose USA, Inc
Jiannan Lu
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Oral dosage form containing theobromine-free cocoa
Patent number
12,285,488
Issue date
Apr 29, 2025
LTS Lohmann Therapie-Systeme AG
Thomas Hille
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
ASH1L degraders and methods of treatment therewith
Patent number
12,285,490
Issue date
Apr 29, 2025
The Regents of the University of Michigan
Jolanta Grembecka
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Grant
Medical moisturizing eye patch and preparation method thereof
Patent number
12,285,530
Issue date
Apr 29, 2025
Zhende Medical Co., Ltd.
Jiao Wang
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Method for modulating metabolism
Patent number
12,285,392
Issue date
Apr 29, 2025
Brightseed, Inc.
Lee Heil Chae
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Composition comprising bornyl acetate or pharmaceutically acceptabl...
Patent number
12,285,399
Issue date
Apr 29, 2025
University-Industry Cooperation Group of Kyung Hee University
Ik-Hyun Cho
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Methods and compositions for the treatment of snake bite
Patent number
12,285,408
Issue date
Apr 29, 2025
Liverpool School of Tropical Medicine
Nicholas Casewell
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
2-(5-aminopyridin-2-yl)-N-benzylacetamides and use thereof in the t...
Patent number
12,285,418
Issue date
Apr 29, 2025
University of Jeddah
Roaa M. Alreemi
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Bupivacaine multivesicular liposome formulations and uses thereof
Patent number
12,285,419
Issue date
Apr 29, 2025
Pacira Pharmaceuticals, Inc.
Louie D. Garcia
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Uses of piperidinyl-indole derivatives
Patent number
12,285,422
Issue date
Apr 29, 2025
Novartis AG
Jorg Eder
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Glucocorticoid receptor modulators to treat cervical cancer
Patent number
12,285,425
Issue date
Apr 29, 2025
Corcept Therapeutics, Inc.
Hazel Hunt
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Inhibitors of receptor interacting protein kinase I for the treatme...
Patent number
12,286,406
Issue date
Apr 29, 2025
Board of Regents, The University of Texas System
Richard T. Lewis
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Treatment of Rb-negative tumors using topoisomerase inhibitors in c...
Patent number
12,285,431
Issue date
Apr 29, 2025
Pharmacosmos Holding A/S
Jay Copeland Strum
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Treatment of hair loss disorders with deuterated JAK inhibitors
Patent number
12,285,432
Issue date
Apr 29, 2025
Sun Pharmaceutical Industries, Inc.
James V. Cassella
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Reversing the undesirable pH-profile of doxorubicin via activation...
Patent number
12,285,437
Issue date
Apr 29, 2025
The Research Foundation for the State University of New York
Ming An
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Weight management composition
Patent number
12,285,456
Issue date
Apr 29, 2025
Exerkine Corporation
Mark Tarnopolsky
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Liquid topical pharmaceutical nano-emulsion formulations
Patent number
12,285,487
Issue date
Apr 29, 2025
JRX Biotechnology, Inc.
Frederick L. Jordan
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Bone targeted antimicrobial oxazolidinone related compounds, formul...
Patent number
12,285,489
Issue date
Apr 29, 2025
Frank Hallock Ebetino
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
System and method for non-surgical treatment of prolapsed hemorrhoids
Patent number
12,285,391
Issue date
Apr 29, 2025
Gloria McCarthy
B08 - CLEANING
Information
Patent Grant
Co-crystal of ketoprofen, compositions comprising the same, process...
Patent number
12,285,396
Issue date
Apr 29, 2025
DOMPE' FARMACEUTICI S.P.A.
Andrea Aramini
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Water soluble compositions comprising purified cannabinoids
Patent number
12,285,405
Issue date
Apr 29, 2025
Canopy Growth Corporation
Kurt Aron Levy
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Method of treating cancer with a selenide
Patent number
12,285,406
Issue date
Apr 29, 2025
IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY
Tarek Ahmed Yousef
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Methods of treating hepatic encephalopathy
Patent number
12,285,414
Issue date
Apr 29, 2025
Salix Pharmaceuticals, Inc.
William Forbes
Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information
Patent Grant
Stable nimodipine parenteral formulation
Patent number
12,285,420
Issue date
Apr 29, 2025
ACASTI PHARMA U.S., INC
S. George Kottayil
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Treatment of a senescence-associated ocular disease or disorder usi...
Patent number
12,285,427
Issue date
Apr 29, 2025
Unity Biotechnology, Inc.
Remi-Martin Laberge
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Grant
Modulation of glucose bioaccessibility with superabsorbent materials
Patent number
12,285,738
Issue date
Apr 29, 2025
Lijun Sun
B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Patents Applications
last 30 patents
Information
Patent Application
PHARMACEUTICAL COMPOSITION FOR DRY POWDER INHALATION AND PREPARATIO...
Publication number
20250134806
Publication date
May 1, 2025
ASG INSPIRATION LABORATORY (SINGAPORE) PTE. LTD.
Sung Tsai YU
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
SUSPENSION CONTAINING HETEROCYCLIDENE ACETAMIDE DERIVATIVE
Publication number
20250134808
Publication date
May 1, 2025
SENJU PHARMACEUTICAL CO., LTD.
Yuki YAMASHITA
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
ULTRAFLEXIBLE LIPOSOMES IN GEL FORMULATION
Publication number
20250134811
Publication date
May 1, 2025
The Research Foundation for The State University of New York
Anthony Di Pasqua
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ES...
Publication number
20250134818
Publication date
May 1, 2025
Impax Laboratories, LLC
Ann Hsu
Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information
Patent Application
METHOD FOR PRODUCING MEDICATIONS AND VACCINES
Publication number
20250134825
Publication date
May 1, 2025
MSLsolutions GmbH
Gerd Herbert DAHMS
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
MOLECULAR SOLID SUSPENSIONS FOR TRANSDERMAL DRUG DELIVERY
Publication number
20250134828
Publication date
May 1, 2025
Starton Therapeutics, Inc.
Rod L. Hartwig
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
RETINOL FORMULATION (IV)
Publication number
20250134834
Publication date
May 1, 2025
DSM IP Assets B. V.
Linda HAENDEL
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
A COMBINATION COMPOSITION
Publication number
20250134839
Publication date
May 1, 2025
AFT PHARMACEUTICALS LIMITED
Hartley C. Atkinson
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
PHARMACEUTICAL COMPOSITION OF BEMPEDOIC ACID
Publication number
20250134841
Publication date
May 1, 2025
SYNTHON B.V.
Marta VIVANCOS MARTINEZ
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OCULAR DISEAS...
Publication number
20250134849
Publication date
May 1, 2025
DAEWOONG THERAPEUTICS INC.
Sanghan PARK
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
PLANT-DERIVED SMALL MOLECULES AS MARBURG VIRUS INHIBITORS
Publication number
20250134850
Publication date
May 1, 2025
Leena Hussein BAJRAI
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Fast Acting Joint Health Composition and Use Thereof
Publication number
20250134857
Publication date
May 1, 2025
Lonza Greenwood LLC
Vijaya Juturu
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Compositions And Methods For The Treatment Of Depression
Publication number
20250134859
Publication date
May 1, 2025
JANSSEN PHARMACEUTICALS, INC
Mark Schmidt
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
COMMENSAL SIGNALLING COMPOUNDS FOR TREATING OR PREVENTING MICROBIOM...
Publication number
20250134866
Publication date
May 1, 2025
Jan TRAMPOTA
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
UPR MODULATORS TO TREAT HEARING LOSS
Publication number
20250134871
Publication date
May 1, 2025
JACARANDA BIOSCIENCES, INC.
Russell Dahl
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
ANTITUMOR COMPOSITION
Publication number
20250134872
Publication date
May 1, 2025
OTSUKA PHARMACEUTICAL CO., LTD.
Naoto OHI
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
METHODS OF TREATING CANCER DEPENDENT ON MYC GENE EXPRESSSION
Publication number
20250134877
Publication date
May 1, 2025
Wayne Rothbaum
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
USE OF SHP2 INHIBITORS FOR INHIBITING SENESCENCE
Publication number
20250134885
Publication date
May 1, 2025
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Armelle YART
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
DRUG REPURPOSING FOR DELAYED TREATMENT OF ISCHEMIC STROKE
Publication number
20250134902
Publication date
May 1, 2025
UNIVESRITY OF NORTH TEXAS HEALTH SCIENCE CENTER
Derek SCHREIHOFER
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
USE OF SMALL-MOLECULE COMPOUND HOMOHARRINGTONINE IN MANUFACTURING D...
Publication number
20250134905
Publication date
May 1, 2025
HANGZHOU CITY UNIVERSITY
Geng YANG
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS
Publication number
20250134911
Publication date
May 1, 2025
Rush University Medical Center
Kalipada Pahan
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
SUPERABSORBENT HYDROGELS WITH LIPASE INHIBITOR
Publication number
20250134923
Publication date
May 1, 2025
JUNION LABS PTE. LTD.
Jingnan LUO
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Composition for Prevention and Treatment of Bacterial and Viral Inf...
Publication number
20250134924
Publication date
May 1, 2025
David A. Cuddeback
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
COMPOSITION FOR ANTI-CANCER TREATMENT COMPRISING IMMUNOGENIC TUMOR-...
Publication number
20250134926
Publication date
May 1, 2025
Research & Business Foundation Sungkyunkwan University
Jae Hyung PARK
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Application
METHOD AND SYSTEM FOR MANUFACTURING DOSING CAPSULES FOR CANNABIS-DE...
Publication number
20250134773
Publication date
May 1, 2025
CAPHEADS LLC
Ori LIEBERMAN
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
TREATMENT OF HODGKIN LYMPHOMA USING AN ANTI-PD-1 ANTIBODY
Publication number
20250134996
Publication date
May 1, 2025
Bristol-Myers Squibb Company
Benedetto FARSACI
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
ANTI-ROR1 ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI ROR1 AN...
Publication number
20250135025
Publication date
May 1, 2025
Sturo Biopharma, Inc.
Amandeep Gakhal
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
ANTAGONISTS OF CAV 2.3
Publication number
20250136552
Publication date
May 1, 2025
LARIO THERAPEUTICS LIMITED
Henning STEINHAGEN
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF US...
Publication number
20250136556
Publication date
May 1, 2025
Allianthera (Suzhou) Biopharmaceutical Co., Ltd.
Jinshan Chen
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
THIADIAZOLONE DERIVATIVES USEFUL AS AMPK ACTIVATOR
Publication number
20250136563
Publication date
May 1, 2025
BETAGENON AB
Thomas Edlund
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE